BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32076456)

  • 1. Tissue Infiltrating Immune Cells as Prognostic Biomarkers in Endometrial Cancer: A Meta-Analysis.
    Guo F; Dong Y; Tan Q; Kong J; Yu B
    Dis Markers; 2020; 2020():1805764. PubMed ID: 32076456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer.
    Li J; Wang J; Chen R; Bai Y; Lu X
    Oncotarget; 2017 Feb; 8(9):15621-15631. PubMed ID: 28152503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Role of Tumor-Infiltrating Lymphocytes in Esophagus Cancer: a Meta-Analysis.
    Zheng X; Song X; Shao Y; Xu B; Hu W; Zhou Q; Chen L; Zhang D; Wu C; Jiang J
    Cell Physiol Biochem; 2018; 45(2):720-732. PubMed ID: 29414812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer.
    de Jong RA; Leffers N; Boezen HM; ten Hoor KA; van der Zee AG; Hollema H; Nijman HW
    Gynecol Oncol; 2009 Jul; 114(1):105-10. PubMed ID: 19411095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8, FoxP3, and CD45RO+ Lymphocytic Infiltrates in Type I and Type II Endometrial Cancers in African American and European American Females.
    Rashid T; Young-Pierce JL; Garrett-Mayer E; Graybill W; Neal S; Spruill LS
    Int J Gynecol Pathol; 2017 Nov; 36(6):540-549. PubMed ID: 28114190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prognostic Value of FoxP3+ Tumour-Infiltrating Lymphocytes in Rectal Cancer Depends on Immune Phenotypes Defined by CD8+ Cytotoxic T Cell Density.
    Schnellhardt S; Hirneth J; Büttner-Herold M; Daniel C; Haderlein M; Hartmann A; Fietkau R; Distel L
    Front Immunol; 2022; 13():781222. PubMed ID: 35140715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis.
    Orhan A; Vogelsang RP; Andersen MB; Madsen MT; Hölmich ER; Raskov H; Gögenur I
    Eur J Cancer; 2020 Jun; 132():71-84. PubMed ID: 32334338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Role of Tumor-Infiltrating Lymphocytes in Lung Cancer: a Meta-Analysis.
    Geng Y; Shao Y; He W; Hu W; Xu Y; Chen J; Wu C; Jiang J
    Cell Physiol Biochem; 2015; 37(4):1560-71. PubMed ID: 26513143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of CD45RO+ tumor-infiltrating lymphocytes in post-operative survival of breast cancer patients.
    Ahmadvand S; Faghih Z; Montazer M; Safaei A; Mokhtari M; Jafari P; Talei AR; Tahmasebi S; Ghaderi A
    Cell Oncol (Dordr); 2019 Jun; 42(3):343-356. PubMed ID: 30825183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic value of tumor infiltration immune cells in pancreatic cancer].
    Zhao KL; Liu J; Jiang WN; Hao JH
    Zhonghua Wai Ke Za Zhi; 2018 Jun; 56(6):464-470. PubMed ID: 29886672
    [No Abstract]   [Full Text] [Related]  

  • 11. The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis.
    Zhao Y; Ge X; He J; Cheng Y; Wang Z; Wang J; Sun L
    World J Surg Oncol; 2019 May; 17(1):85. PubMed ID: 31118034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
    Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of the common tumour-infiltrating lymphocyte subtypes for patients with non-small cell lung cancer: A meta-analysis.
    Chen B; Li H; Liu C; Xiang X; Wang S; Wu A; Shen Y; Li G
    PLoS One; 2020; 15(11):e0242173. PubMed ID: 33170901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-infiltrating CD45RO
    Hu G; Wang S
    Sci Rep; 2017 Sep; 7(1):10376. PubMed ID: 28871164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapy.
    Dieci MV; Tsvetkova V; Griguolo G; Miglietta F; Tasca G; Giorgi CA; Cumerlato E; Massa D; Lo Mele M; Orvieto E; Guarneri V; Conte P
    Eur J Cancer; 2020 Sep; 136():7-15. PubMed ID: 32622323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Significance of Tumor-Infiltrating Natural Killer Cells in Solid Tumors: A Systematic Review and Meta-Analysis.
    Zhang S; Liu W; Hu B; Wang P; Lv X; Chen S; Shao Z
    Front Immunol; 2020; 11():1242. PubMed ID: 32714321
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic Value of CD45Ro
    Koike K; Nishiyama K; Dehari H; Ogi K; Sasaki T; Shimizu S; Sasaya T; Tsuchihashi K; Sonoda T; Hasegawa T; Hiratsuka H; Miyazaki A
    Anticancer Res; 2021 Sep; 41(9):4515-4522. PubMed ID: 34475077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic benefit of tumour-infiltrating Natural Killer cells in endometrial cancer is dependent on concurrent overexpression of Human Leucocyte Antigen-E in the tumour microenvironment.
    Versluis MAC; Marchal S; Plat A; de Bock GH; van Hall T; de Bruyn M; Hollema H; Nijman HW
    Eur J Cancer; 2017 Nov; 86():285-295. PubMed ID: 29059634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma.
    Workel HH; Komdeur FL; Wouters MC; Plat A; Klip HG; Eggink FA; Wisman GB; Arts HJ; Oonk MH; Mourits MJ; Yigit R; Versluis M; Duiker EW; Hollema H; de Bruyn M; Nijman HW
    Eur J Cancer; 2016 Jun; 60():1-11. PubMed ID: 27038842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of intratumoral and peritumoral tumor-infiltrating FoxP3+Treg cells in of pancreatic adenocarcinoma: a meta-analysis.
    Hu L; Zhu M; Shen Y; Zhong Z; Wu B
    World J Surg Oncol; 2021 Oct; 19(1):300. PubMed ID: 34654443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.